Inventor
LADOUCEUR GAETAN H
US14 patents
⚠️ This page may combine multiple inventors who share the name “LADOUCEUR GAETAN H”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BAYER PHARMACEUTICALS CORP
8 patentsUS6660752B2Dec 9, 2003
2,6-Substituted chroman derivatives useful as beta-3 adrenoreceptor agonists
BAYER PHARMACEUTICALS CORP24 citations92
US6699860B2Mar 2, 2004
Di-substituted aminomethyl-chroman derivative beta-3 adrenoreceptor agonists
BAYER PHARMACEUTICALS CORP8 citations71
US6919371B2Jul 19, 2005
2,6-substituted chroman derivatives useful as beta-3 adrenoreceptor agonists
BAYER PHARMACEUTICALS CORP2 citations62
US6780859B2Aug 24, 2004
Benzofuran and dihydrobenzofuran derivatives useful as beta-3 adrenoreceptor agonists
BAYER PHARMACEUTICALS CORP3 citations62
US6903218B2Jun 7, 2005
Sulfonamide substituted chroman derivatives
BAYER PHARMACEUTICALS CORP0 citations51
US7803956B2Sep 28, 2010
Benzofuran derivatives useful for treating hyper-proliferative disorders
BAYER PHARMACEUTICALS CORP0 citations49
US7420066B2Sep 2, 2008
Benzofuran derivatives useful for treating hyper-proliferative disorders
BAYER PHARMACEUTICALS CORP0 citations49
US7238701B2Jul 3, 2007
Substituted tetrahydrobenzothienopyrimidinamine compounds useful for treating hyper-proliferative disorders
BAYER PHARMACEUTICALS CORP0 citations39
BAYER AG
6 patentsUS6218431B1Apr 17, 2001
Substituted biphenyls
BAYER AG93 citations96
US5939462AAug 17, 1999
NPY5 receptor antagonists and methods for using same
BAYER AG117 citations96
US6410792B1Jun 25, 2002
Amide derivatives and methods for using the same as selective neuropeptide Y receptor antagonists
BAYER AG55 citations95
US6245817B1Jun 12, 2001
NPY5 receptor antagonists and methods for using same
BAYER AG46 citations91
US6048900AApr 11, 2000
Amide derivatives and methods for using the same as selective neuropeptide Y receptor antagonists
BAYER AG41 citations91
US6051586AApr 18, 2000
Sulfonamide substituted chroman derivatives useful as beta 3 adrenoreceptor agonists
BAYER AG12 citations72